Bridget N J Watson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Bridget N J Watson

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Nature|March 4, 2020

Publisher Correction: Targeting of temperate phages drives loss of type I CRISPR-Cas systemsClare Rollie, Anne Chevallereau, Bridget N J Watson, et al.

The ISME Journal|February 16, 2024

CRISPR-Cas in Pseudomonas aeruginosa provides transient population-level immunity against high phage exposuresBridget N J Watson, Loris Capria, Ellinor O Alseth, et al.

Nucleic Acids Research|July 4, 2014

Priming in the Type I-F CRISPR-Cas system triggers strand-independent spacer acquisition, bi-directionally from the primed protospacerCorinna Richter, Ron L Dy, Rebecca E McKenzie, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Nature|March 4, 2020

Publisher Correction: Targeting of temperate phages drives loss of type I CRISPR-Cas systemsClare Rollie, Anne Chevallereau, Bridget N J Watson, et al.

The ISME Journal|February 16, 2024

CRISPR-Cas in Pseudomonas aeruginosa provides transient population-level immunity against high phage exposuresBridget N J Watson, Loris Capria, Ellinor O Alseth, et al.

Nucleic Acids Research|July 4, 2014

Priming in the Type I-F CRISPR-Cas system triggers strand-independent spacer acquisition, bi-directionally from the primed protospacerCorinna Richter, Ron L Dy, Rebecca E McKenzie, et al.

Pageof 2